THOMAS TAYLOR: Open Payments
NPI 1700866621 · YULEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,159 in 84 payments from 25 companies in 2025. Trend: 2023 $2,505 · 2024 $2,418 · 2025 $2,159
Food & beverage: $2,159
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $320 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $221 |
| Novo Nordisk Inc | 10 | $189 |
| Abbott Laboratories | 7 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $154 |
| ABBVIE INC. | 7 | $151 |
| Madrigal Pharmaceuticals | 1 | $143 |
| Lilly USA, LLC | 5 | $96 |
| Dexcom, Inc. | 1 | $90 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
Products named: JARDIANCE, BREZTRI, FREESTYLE LIBRE 3, Kerendia, REZDIFFRA, AIRSUPRA, Ozempic, MOUNJARO.
Industry payments across FL — which companies pay providers there.
